↓ Skip to main content

Dove Medical Press

Intravitreal Ziv-Aflibercept versus Bevacizumab for Naïve Central Retinal Vein Occlusion with Macular Edema: An Interim Analysis of a Randomized Non-Inferiority Trial

Overview of attention for article published in Clinical Ophthalmology, September 2023
Altmetric Badge

Mentioned by

twitter
2 X users

Readers on

mendeley
1 Mendeley
Title
Intravitreal Ziv-Aflibercept versus Bevacizumab for Naïve Central Retinal Vein Occlusion with Macular Edema: An Interim Analysis of a Randomized Non-Inferiority Trial
Published in
Clinical Ophthalmology, September 2023
DOI 10.2147/opth.s428792
Pubmed ID
Authors

Suthasinee Sinawat, Suthasinee Hemanak, Kwanchanok Chanthowong, Supat Sinawat, Yosanan Yospaiboon

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 September 2023.
All research outputs
#20,673,680
of 25,394,764 outputs
Outputs from Clinical Ophthalmology
#2,606
of 3,715 outputs
Outputs of similar age
#252,563
of 353,101 outputs
Outputs of similar age from Clinical Ophthalmology
#30
of 108 outputs
Altmetric has tracked 25,394,764 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,715 research outputs from this source. They receive a mean Attention Score of 4.9. This one is in the 13th percentile – i.e., 13% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 353,101 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 108 others from the same source and published within six weeks on either side of this one. This one is in the 9th percentile – i.e., 9% of its contemporaries scored the same or lower than it.